secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001213900-26-049967
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OSR Holdings signs $815M VXM01 license with BCM Europe; largest shareholder pledges entire stake as collateral
--------------------------------------------------------------------------------

- Up to $815M in milestone payments from BCM Europe for VXM01 oral immunotherapy platform (Phase 3-ready VEGFR-2 target).
- BCM Europe pledges its entire 9,974,728 shares (~29.7% of OSRH) as collateral for milestone obligations; pledge effective Feb 2028.
- OSRH to acquire full VXM01 IP from Vaximm AG for $30M via separate asset purchase agreement.
- OSRH receives $15M equity put option at $10/share, exercisable after six months post-effective date.
- All downstream royalties after BCME recovers investment and preferred return flow to OSRH.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026049967/0001213900-26-049967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026049967/ea0288465-8k_osrhold.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-049967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer